COST-EFFECTIVENESS OF DENOSUMAB FOR THE TREATMENT OF MALE OSTEOPOROSIS (MOP) IN THE ELDERLY IN SWEDEN

被引：0
|
作者：
Parthan, A. [1 ]
Deflin, M. M. [1 ]
Agodoa, I [2 ]
Tao, C. Y. [1 ]
Silverman, S. L. [3 ]
Orwoll, E. [4 ]
机构：
[1] OptumInsight, Medford, MA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Cedars Sinai Hosp, Beverly Hills, CA USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1395
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A446 / A446
页数：1
相关论文
共 50 条
  • [1] DENOSUMAB FOR THE TREATMENT OF MALE OSTEOPOROSIS IN THE ELDERLY IN SWEDEN: A COST-EFFECTIVENESS ANALYSIS
    Agodoa, Irene
    Kruse, Morgan
    Parthan, Anju
    Tao, Charles
    Silverman, Stuart
    Orwoll, Eric
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S40 - S40
  • [2] COST-EFFECTIVENESS OF DENOSUMAB FOR THE TREATMENT OF ELDERLY WOMEN WITH POST-MENOPAUSAL OSTEOPOROSIS IN SWEDEN
    Lundkvist, J.
    Loethgren, M.
    Badamgarav, E.
    Freyschyss, B.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A445 - A446
  • [3] IS DENOSUMAB COST-EFFECTIVE COMPARED TO ORAL BISPHOSPHONATES FOR THE TREATMENT OF MALE OSTEOPOROSIS (MOP) IN SWEDEN?
    Parthan, A.
    Kruse, M. M.
    Agodoa, I
    Tao, C. Y.
    Silverman, S. L.
    Orwoll, E.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A223 - A223
  • [4] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    Jonsson, B.
    Strom, O.
    Eisman, J. A.
    Papaioannou, A.
    Siris, E. S.
    Tosteson, A.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 967 - 982
  • [5] Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    [J]. Osteoporosis International, 2011, 22 : 967 - 982
  • [6] Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
    B. Jönsson
    O. Ström
    J. A. Eisman
    A. Papaioannou
    E. S. Siris
    A. Tosteson
    J. A. Kanis
    [J]. Osteoporosis International, 2012, 23 : 2063 - 2065
  • [7] Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
    Choo, Y. W.
    Mohd Tahir, N. A.
    Mohamed Said, M. S.
    Li, S. C.
    Makmor Bakry, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (09) : 1909 - 1923
  • [8] COST-EFFECTIVENESS OF DENOSUMAB IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN SCOTLAND
    Davies, A.
    Compston, J.
    Ferguson, S.
    McClosky, E.
    Shearer, A.
    Taylor, A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A310 - A310
  • [9] Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis
    Jonsson, B.
    Stroem, O.
    Eisman, J. A.
    Papaioannou, A.
    Siris, E. S.
    Tosteson, A.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (07) : 2063 - 2065
  • [10] Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia
    Y. W. Choo
    N. A. Mohd Tahir
    M. S. Mohamed Said
    S. C. Li
    M. Makmor Bakry
    [J]. Osteoporosis International, 2022, 33 : 1909 - 1923
12345